[Depression and inflammation in rheumatic diseases]

Area of Science:

• Neuroimmunology
• Psychiatry
• Rheumatology

Background:

• Higher depression prevalence in rheumatologic patients suggests biological, not solely socioeconomic, causes.
• Sickness behavior symptoms in chronic inflammatory diseases overlap with depression.
• The monoaminergic theory of depression may involve immune system disturbances.

Purpose of the Study:

• To explore the link between immune system dysregulation and mood disorders in rheumatologic patients.
• To investigate the role of inflammatory cytokines and the kynurenine pathway in depression.
• To highlight the significance of neuroendocrine-immune system communication in treatment and neuroprotection.

Main Methods:

• Review of existing literature on depression, inflammation, and the neuroendocrine-immune axis.
• Analysis of the role of cytokines (IL-1, IL-2, IL-6, TNF-α, IFN-γ) in central nervous system (CNS) function.
• Examination of the indoleamine 2,3-dioxygenase (IDO) pathway and its metabolites (3-hydroxykynurenine, quinolinic acid, kynurenic acid).

Main Results:

• Pro-inflammatory cytokines correlate with depression severity and serotonin transporter gene polymorphism.
• Glucocorticoid resistance and activation of the limbic-hypothalamic-pituitary-adrenal (LHPA) axis are linked to cytokine activity.
• IDO activation by cytokines leads to neurotoxic metabolites that disrupt neurotransmission and activate monoamine oxidase (MAO).

Conclusions:

• Depression in immune-mediated diseases involves complex interactions between the immune, neuroendocrine, and central nervous systems.
• Biochemical pathways, including IDO activation and subsequent metabolite production, play a crucial role in the pathophysiology of depression.
• Targeting the bidirectional communication between these systems is essential for effective depression treatment and CNS protection.